Status: Not Logged In; Sign In

National News
See other National News Articles

Title: JNJ Shares Tumble After Reporting Vaccine Effectiveness
Source: [None]
URL Source: ... eporting-vaccine-effectiveness
Published: Jan 29, 2021
Author: Tyler Durden
Post Date: 2021-01-29 13:29:52 by Horse
Keywords: None
Views: 41
Comments: 4

Johnson & Johnson, the biggest pharmaceutical company in the world, has just released the first round of results from its Phase 3 COVID-19 vaccine trials, and they are disappointing.

They showed that the vaccine is only 66% effective at preventing moderate and severe COVID-19 (and that's excluding mild cases of the virus), which is less than Moderna, Pfizer, AstraZeneca and others in the west.

However, western media like the FT highlighted the fact that the vaccine is, at the very least, still 57% effective against the South African variant - which is...not exactly reassuring.

The vaccine showed some protection against the 501. V2 variant, which first emerged in South Africa, although efficacy was 57 per cent in trials conducted there. The jab showed an efficacy rate of 72 per cent in the US, and 66 per cent in Latin America. Alex Gorsky, J&J’s chief executive, called the results a “critical milestone”. The company intends to file for a US emergency use authorisation in early February and, if granted, will immediately be able to ship vaccines. “Our goal all along has been to create a simple, effective solution for the largest number of people possible, and to have maximum impact to help end the pandemic,” he said.

The FT also noted that the trial results for JNJ aren't exactly comparable to other vaccines. It also noted that the vaccine doesn't require cold temperatures, and can be delivered in a single dose, all of which are advantages over vaccines produced by rivals like Pfizer and Moderna.

Chief Scientific Officer Paul Stoffels added that "a one-shot vaccine is considered by the World Health Organization to be the best option in pandemic settings, enhancing access, distribution and compliance."

That's critical, since the trial data released last night by Novavax showed that the US OWS-backed vaccine wasn't nearly as effective against the mutated virus than the version in the UK.

Given the fact that it's a Dow component, JNJ shares are taking down the whole index, and contributing to a broader selloff in value stocks as the news was viewed as an important reflationary catalyst.

JNJ's results follow Novavax's and Moderna's announced plans for trials of vaccines designed to tackle the 501. V2 "variant" - ie the mutation first isolated in South Africa - after data showed that both vaccines weren't as effective against the variant (remember all those scientists including Dr. Anthony Fauci and top officials at the WHO who insisted mutations wouldn't be a problem?)

The results are just the latest reminder that the fantastic results promised by Dr. Anthony Fauci and former FDA chief Dr. Scott Gottlieb (aka CNBC's go-to COVID expert) far outstrip the reality. The two experts both touted the Johnson & Johnson vaccine as almost guaranteed to be one of the safest and most effective vaccines. But it's not the first time they were wrong. Dr. Fauci touted the results earlier this week.

Of course, one can't help but question results from other trials as well, given the low numbers of infected patients, and the rush to the finish line.

Poster Comment:

So what if it doesn't work? It is not as dangerous as Pfizer and Moderna.

Post Comment   Private Reply   Ignore Thread  

TopPage UpFull ThreadPage DownBottom/Latest

Begin Trace Mode for Comment # 4.

#1. To: Horse (#0)

It is not as dangerous as Pfizer and Moderna.

An old friend called me last night. I guess she's going to get the Moderna shot Monday.

Last week, she was dead-set against vaxes, but the folks at the senior living apts where she's at must've browbeat or shamed her into it.

What are her chances? She's in her mid 70s.

Esso  posted on  2021-01-29   14:37:02 ET  Reply   Untrace   Trace   Private Reply  

#2. To: Esso (#1)

Moderna is more dangerous even than Pfizer. Both are bad. Can she wait for the Johnson And Johnson vaccine?

Horse  posted on  2021-01-29   15:11:32 ET  Reply   Untrace   Trace   Private Reply  

#3. To: Horse, 4um (#2)

Moderna is more dangerous even than Pfizer. Both are bad.

I appreciate your input, Hoss. I know vaxxes are bad, but I thought the Moderna might be a little less virulent given that it isn't so unstable as to require cryogenic storage conditions.

The gal called me a while ago and let me know the vax is a no-go for her. After I told her my reservations, she tried to call her son (anti-vaxxer and AJ follower) and can't get ahold of him.

She told me that she called her MD and said she was having allergy problems and a slight earache. Her MD told her no way. I'm glad for her. I told her what you thought about the vaxxes and she seemed to be relieved. She mentioned last night that she was having anxiety problems over the vaxx. I'm pretty sure she was being browbeaten, I didn't bring it up.

Between your knowledge and my hesitancy, we might have saved an old lady. I guess that's something, brother.

Esso  posted on  2021-01-29   17:32:16 ET  Reply   Untrace   Trace   Private Reply  

#4. To: Esso (#3)

There's some great news -- hope she stands firm. I wonder how she knew to ask her doctor about the vax in relation to allergies -- maybe read some kind of info sheet or her son clued her.

NeoconsNailed  posted on  2021-01-29   17:43:46 ET  Reply   Untrace   Trace   Private Reply  

Replies to Comment # 4.

        There are no replies to Comment # 4.

End Trace Mode for Comment # 4.

TopPage UpFull ThreadPage DownBottom/Latest